PM
Puneet Mahajan
About Puneet Mahajan
Data last updated:
Puneet Mahajan is a Director at Alisier Drugs Private Limited (since 2011) and Director at Voopar Sciences Private Limited (since 2017). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹4.70 Cr; the largest is Alisier Drugs Private Limited at ₹3.06 Cr (FY 2024). Earlier, Puneet Mahajan was a Director at Evantis Lifesciences Private Limited (2016–2020) and Director at Torance Health Care Private Limited (2015–2017) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Dec 2011 | 2011 | ₹3.06 Cr (FY 2024) | Active | |
| Director | 17 Oct 2017 | 2017 | ₹1.64 Cr (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Feb 2016 | 2016 | ₹6.6 Lakh (FY 2023) | Active | |
| Director | 30 Jun 2015 | 2015 | ₹3.00 Cr (FY 2025) | Active | |
| Director | 23 Jun 2016 | 2016 | ₹1.66 Cr (FY 2025) | Active | |
| Director | 26 Feb 2014 | 2014 | ₹86.8 Lakh (FY 2025) | Active | |
| Director | 18 Feb 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Puneet Mahajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Renu Sinha | 06956113 | Alisier Drugs Private Limited | Director |
| Varesh Khanna | 05142658 | Alisier Drugs Private Limited | Director |
| Ritu Chawla | 07962911 | Voopar Sciences Private Limited | Director |
| Vaishali Mahajan | 09512725 | Voopar Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Puneet Mahajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Puneet Mahajan
Puneet Mahajan currently holds 2 directorships: Alisier Drugs Private Limited (Director, since 28 Dec 2011, revenue ₹3.06 Cr (FY 2024)); Voopar Sciences Private Limited (Director, since 17 Oct 2017, revenue ₹1.64 Cr (FY 2024)).
Puneet Mahajan was first appointed on 28 Dec 2011 as Director at Alisier Drugs Private Limited. The most recent appointment on record is 18 Feb 2019 at Raosch Lifesciences Private Limited.
The 2 current companies of Puneet Mahajan that report revenue have a combined latest revenue of ₹4.70 Cr: Alisier Drugs Private Limited ₹3.06 Cr (FY 2024); Voopar Sciences Private Limited ₹1.64 Cr (FY 2024).
Puneet Mahajan held 5 earlier board appointments: Evantis Lifesciences Private Limited (Director, 16 Feb 2016 to 12 Feb 2020); Torance Health Care Private Limited (Director, 30 Jun 2015 to 23 May 2017); Zerdia Healthcare Private Limited (Director, 23 Jun 2016 to 18 Feb 2019); Jonas Pharmaceuticals Private Limited (Director, 26 Feb 2014 to 27 Feb 2019); Raosch Lifesciences Private Limited (Director, from 18 Feb 2019).
The current boards of Puneet Mahajan's companies include Renu Sinha (Alisier Drugs Private Limited), Varesh Khanna (Alisier Drugs Private Limited), Ritu Chawla (Voopar Sciences Private Limited), Vaishali Mahajan (Voopar Sciences Private Limited).